InsidersTradesSigma
Follow the IME share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Health Care sector, IME has recorded 2 insider filings. Market capitalisation: €17.4m. The latest transaction was disclosed on 12 June 2026 (Sale). Among the most active insiders: Damian Banks. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IME 是一家在健康和制药领域运营的公司，在 XASX 上市。它专注于开发创新解决方案以改善医疗保健。